Wall Street analysts expect Equifax (EFX) to post quarterly earnings of $1.92 per share in its upcoming report, which indicates a year-over-year increase of 5.5%. Revenues are expected to be $1.51 ...

Even if a company is profitable, it doesn’t always mean it’s a great investment. Some struggle to maintain growth, face ...

EFX is set to report Q2 results on July 22, with EPS and revenues expected to rise on solid USIS, international and Workforce ...

Efx Fragments is available now at an introductory price of $99, though if you already own other Arturia products there's probably a steep discount waiting for you.

Find the latest Equifax, Inc. EFX analyst stock forecast, price target, and recommendation trends with in-depth analysis from research reports.

Akero Therapeutics reports a 39% improvement in cirrhosis patients using EFX. See why AKRO stock is soaring with the breakthrough Phase 2b SYMMETRY data.

Akero Therapeutics' week 96 Harmony trial data findings and reporting warrant caution. Click here to see why AKRO stock is a Sell.

Investors in Equifax Inc (Symbol: EFX) saw new options begin trading today, for the April 2025 expiration. One of the key data points that goes into the price an option buyer is willing to pay, is ...